Clinical Trial Update: Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer

View source ↗

Summary

A clinical trial evaluating how BRCA1/2 gene variants affect treatment response and prognosis in ovarian cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Ovarian Cancer | Status: RECRUITING